Beta-blockers and lipophilicity.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D006801:Humans; D008055:Lipids; D008297:Male; D012995:Solubility; D019966:Substance-Related Disorders / Q000209:etiology*
D000319:Adrenergic beta-Antagonists; D008055:Lipids